Minimus Spine has developed ozone injection technology specifically for spinal applications. Ozone has been used outside the United States to treat disc herniations for over 15 years and there are over 20 peer-reviewed papers documenting over 8,000 patients. This treatment is not available in the United States.
Minimus Spine has improved upon the existing technology through a system that creates ozone and measures its concentration, within a patented, sterile, single-use syringe cartridge. The system is known as Triojection®. Triojection® has advantages in terms of sterility and confidence in the concentration of gas delivered to the patient, as well as material compatibility. All of these improvements are vital to the advancement of this technique.Minimus Spine and the Triojection® system have received the necessary certifications to commercialize Triojection® in Europe (ISO 13485 Certification and EC Certificate). British Standards Institute is Minimus Spine’s Notified Body.Minimus expects to improve patient care and save the health care system significant resources on unnecessary steroid injections and surgeries. http://minimusspine.com
About the Spinal Market
The Spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. On the basis of products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.
The Spinal market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020. As of 2015, North America is estimated to hold the largest share of the global spinal implants and spinal devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2015 to 2020. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness on the newly developed spine treatment techniques and devices are propelling the growth of the spinal implants and spinal devices market in the Asia-Pacific region. However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness restricts the market growth in this region.
Source: marketsandmarkets.com